Drug delivery systems -- Research -- Methodology : In-vitro and in-vivo tools in drug delivery research for optimum clinical outcomes / edited by Ambikanandan Misra and Aliasgar Fakruddin Shahiwala
Drug delivery systems -- Standards : Leachables and extractables handbook : safety evaluation, qualification, and best practices applied to inhalation drug products / edited by Douglas J. Ball [and others]
Drug Delivery Systems -- trends : Drug delivery and targeting for pharmacists and pharmaceutical scientists / edited by Anya M. Hillery, Andrew W. Lloyd, and James Swarbrick
Drug Design -- United States -- Congresses : Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Board on Health Sciences Policy, Institute of Medicine of the National Academies
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis
1
Drug detection. : La Familia Drug Cartel: Implications for U.S.-Mexican Security
Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion
Drug development -- Africa : Drug discovery in Africa : impacts of genomics, natural products, traditional medicines, insights into medicinal chemistry, and technology platforms in pursuit of new drugs / Kelly Chibale, Mike Davies-Coleman, Collen Masimirembwa, editors
2012
1
Drug development -- Canada : Patently innovative : how pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs / Ron A. Bouchard
Drug development -- Economic aspects -- Congresses : Financial incentives to encourage development of therapies that address unmet medical needs for nervous system disorders : workshop summary / Sheena M. Posey Norris, Evelyn Strauss, Christopher DeFeo, and Clare Stroud, rapporteurs ; Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
